525 related articles for article (PubMed ID: 25538205)
1. Progress in aldosteronism: a review of the prevalence of primary aldosteronism in pre-hypertension and hypertension.
Piaditis G; Markou A; Papanastasiou L; Androulakis II; Kaltsas G
Eur J Endocrinol; 2015 May; 172(5):R191-203. PubMed ID: 25538205
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore.
Loh KC; Koay ES; Khaw MC; Emmanuel SC; Young WF
J Clin Endocrinol Metab; 2000 Aug; 85(8):2854-9. PubMed ID: 10946893
[TBL] [Abstract][Full Text] [Related]
3. What We Know about and What Is New in Primary Aldosteronism.
Ekman N; Grossman AB; Dworakowska D
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255973
[TBL] [Abstract][Full Text] [Related]
4. Stress-induced Aldosterone Hyper-Secretion in a Substantial Subset of Patients With Essential Hypertension.
Markou A; Sertedaki A; Kaltsas G; Androulakis II; Marakaki C; Pappa T; Gouli A; Papanastasiou L; Fountoulakis S; Zacharoulis A; Karavidas A; Ragkou D; Charmandari E; Chrousos GP; Piaditis GP
J Clin Endocrinol Metab; 2015 Aug; 100(8):2857-64. PubMed ID: 25974737
[TBL] [Abstract][Full Text] [Related]
5. Genetics of mineralocorticoid excess: an update for clinicians.
Zennaro MC; Rickard AJ; Boulkroun S
Eur J Endocrinol; 2013 Jul; 169(1):R15-25. PubMed ID: 23610123
[TBL] [Abstract][Full Text] [Related]
6. Primary aldosteronism.
Gordon RD
J Endocrinol Invest; 1995; 18(7):495-511. PubMed ID: 9221268
[TBL] [Abstract][Full Text] [Related]
7. Role of ACTH and Other Hormones in the Regulation of Aldosterone Production in Primary Aldosteronism.
El Ghorayeb N; Bourdeau I; Lacroix A
Front Endocrinol (Lausanne); 2016; 7():72. PubMed ID: 27445975
[TBL] [Abstract][Full Text] [Related]
8. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Rossi GP; Bernini G; Caliumi C; Desideri G; Fabris B; Ferri C; Ganzaroli C; Giacchetti G; Letizia C; Maccario M; Mallamaci F; Mannelli M; Mattarello MJ; Moretti A; Palumbo G; Parenti G; Porteri E; Semplicini A; Rizzoni D; Rossi E; Boscaro M; Pessina AC; Mantero F;
J Am Coll Cardiol; 2006 Dec; 48(11):2293-300. PubMed ID: 17161262
[TBL] [Abstract][Full Text] [Related]
9. Primary aldosteronism: hypertension with a genetic basis.
Gordon RD; Klemm SA; Tunny TJ; Stowasser M
Lancet; 1992 Jul; 340(8812):159-61. PubMed ID: 1352575
[TBL] [Abstract][Full Text] [Related]
10. Primary aldosteronism: renaissance of a syndrome.
Young WF
Clin Endocrinol (Oxf); 2007 May; 66(5):607-18. PubMed ID: 17492946
[TBL] [Abstract][Full Text] [Related]
11. [Primary aldosteronism].
Fardella CE; Mosso LM; Carvajal CA
Rev Med Chil; 2008 Jul; 136(7):905-14. PubMed ID: 18949169
[TBL] [Abstract][Full Text] [Related]
12. Is aldosterone the missing link in refractory hypertension?: aldosterone-to-renin ratio as a marker of inappropriate aldosterone activity.
Lim PO; Jung RT; MacDonald TM
J Hum Hypertens; 2002 Mar; 16(3):153-8. PubMed ID: 11896503
[TBL] [Abstract][Full Text] [Related]
13. Primary aldosteronism: who should be screened?
Monticone S; Viola A; Tizzani D; Crudo V; Burrello J; Galmozzi M; Veglio F; Mulatero P
Horm Metab Res; 2012 Mar; 44(3):163-9. PubMed ID: 22120135
[TBL] [Abstract][Full Text] [Related]
14. The aldosterone/renin ratio as a screening test for primary aldosteronism.
Rayner BL; Opie LH; Davidson JS
S Afr Med J; 2000 Apr; 90(4):394-400. PubMed ID: 10957926
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of primary aldosteronism among prehypertensive and stage 1 hypertensive subjects.
Ito Y; Takeda R; Karashima S; Yamamoto Y; Yoneda T; Takeda Y
Hypertens Res; 2011 Jan; 34(1):98-102. PubMed ID: 20927116
[TBL] [Abstract][Full Text] [Related]
16. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology.
Fardella CE; Mosso L; Gómez-Sánchez C; Cortés P; Soto J; Gómez L; Pinto M; Huete A; Oestreicher E; Foradori A; Montero J
J Clin Endocrinol Metab; 2000 May; 85(5):1863-7. PubMed ID: 10843166
[TBL] [Abstract][Full Text] [Related]
17. [Primary hyperaldosteronism: a diagnostic algorithm].
Del Giudice A; Prencipe M; Aucella F
G Ital Nefrol; 2013; 30(3):. PubMed ID: 23832473
[TBL] [Abstract][Full Text] [Related]
18. Prevalence, diagnosis and outcomes of treatment for primary aldosteronism.
Yang Y; Reincke M; Williams TA
Best Pract Res Clin Endocrinol Metab; 2020 Mar; 34(2):101365. PubMed ID: 31837980
[TBL] [Abstract][Full Text] [Related]
19. Screening for primary aldosteronism.
Schirpenbach C; Reincke M
Best Pract Res Clin Endocrinol Metab; 2006 Sep; 20(3):369-84. PubMed ID: 16980200
[TBL] [Abstract][Full Text] [Related]
20. RAS-challenge as a first-look test for detection of primary aldosteronism in patients with treatment-resistant hypertension.
Beger C; Karg T; Hinrichs JB; Ringe B; Haller H; Meyer BC; Limbourg FP
Blood Press; 2023 Dec; 32(1):2179340. PubMed ID: 36803263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
